Early research (Phase 1)Study completedNCT04053023What this trial is testingLinerixibat and Obeticholic Acid Drug Interaction Study in Healthy SubjectsWho this might be right forCholestasis GlaxoSmithKline 19
Early research (Phase 1)Study completedNCT04881994What this trial is testingLearn How Finerenone (BAY94-8862) Moves Into, Through and Out of the Body, How it Affects the Body, and How Safe it is in Adult Participants With Different Degrees of Reduced Liver Function and in Healthy Participants With Similar Age, Weight and Gender DistributionWho this might be right forWorsening Chronic Heart FailureDiabetic Nephropathy Bayer 27
Early research (Phase 1)Study completedNCT04142424What this trial is testingUnderstand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese SubjectsWho this might be right forMetabolic DisordersNon-alcoholic Steatohepatitis AstraZeneca 73
Early research (Phase 1)Study completedNCT06719128What this trial is testingOlomorasib (LY3537982) in Participants With Hepatic Impairment and Healthy ParticipantsWho this might be right forHepatic InsufficiencyHealthy Eli Lilly and Company 46
Not applicableActive Not RecruitingNCT06240039What this trial is testingDirect Versus Indirect Effect of Amino Acids on HepatokinesWho this might be right forNon-Alcoholic Fatty Liver DiseaseObesity University of Copenhagen 30
Early research (Phase 1)Study completedNCT00866853What this trial is testingTMC435-TiDP16-C107: This Study Measures the (Possible) Influence of TMC435 on the Activity of a Selected Set of Drug-degrading Proteins by Measuring the Blood Levels of Drugs That Have Been Taken Together With TMC435 and That Are Known to be Specifically Degraded by These Drug-degrading Proteins.Who this might be right forHepatitis CViruses Tibotec Pharmaceuticals, Ireland 16
Early research (Phase 1)Study completedNCT02186977What this trial is testingProof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-IDWho this might be right forHepatitis B Novosanis NV 48
Early research (Phase 1)Study completedNCT00781430What this trial is testingStudy Evaluating The PK And Safety Of Neratinib In Healthy Subjects And Subjects With Chronic Liver DiseaseWho this might be right forHepatic Insufficiency Puma Biotechnology, Inc. 27
Early research (Phase 1)Study completedNCT02754219What this trial is testingPharmacokinetics and Safety of Evogliptin in Subjects With Hepatic DysfunctionWho this might be right forLiver Dysfunction Dong-A ST Co., Ltd. 24
Early research (Phase 1)Study completedNCT01663922What this trial is testingBoceprevir and Ucalm (St John&Apos;s Wort)Who this might be right forHepatitis C St Stephens Aids Trust 17
Early research (Phase 1)Study completedNCT00416702What this trial is testingSafety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With Impaired Liver FunctionWho this might be right forHepatic Insufficiency Novartis 32
Testing effectiveness (Phase 2)Ended earlyNCT05330455What this trial is testingStudy of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B InfectionWho this might be right forHepatitis B GlaxoSmithKline 74
Very early researchStudy completedNCT04754776What this trial is testingSafety and Immunogenicity of a Candidate RVFV Vaccine (RVF001)Who this might be right forRift Valley Fever University of Oxford 15
Early research (Phase 1)Study completedNCT04174118What this trial is testingStudy of DCR-A1AT in Healthy Adult VolunteersWho this might be right forAlpha 1-Antitrypsin Deficiency Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 30
Early research (Phase 1)Study completedNCT04692025What this trial is testingStudy to Evaluate the Effect of Food on the Pharmacokinetics of ASC41 in Healthy VolunteersWho this might be right forHealthyNAFLDHyperlipidemia Gannex Pharma Co., Ltd. 12
Early research (Phase 1)Study completedNCT02183376What this trial is testingPharmacokinetics and Pharmacodynamics of BI 1356 in Subjects With Different Degrees of Liver Impairment as Compared to Healthy SubjectsWho this might be right forHepatic Insufficiency Boehringer Ingelheim 33
Early research (Phase 1)Study completedNCT02612506What this trial is testingSafety and Pharmacokinetic Study of Hepalatide(L47) in Healthy VolunteersWho this might be right forHepatitis B， Chronic Shanghai HEP Pharmaceutical Co., Ltd. 48
Early research (Phase 1)Study completedNCT00979927What this trial is testingSPC3649 Multiple Dose Study in Healthy VolunteersWho this might be right forHepatitis C Santaris Pharma A/S 30
Early research (Phase 1)Study completedNCT04972396What this trial is testingPemvidutide (ALT-801) DDI Study in Healthy VolunteersWho this might be right forNASH - Nonalcoholic Steatohepatitis Altimmune, Inc. 40
Early research (Phase 1)Study completedNCT04672824What this trial is testingAssess the New Candidate Rift Valley Fever Virus Vaccine in Healthy AdultsWho this might be right forRVFRift Valley Fever University of Oxford 30